The application from Osake-based Japan Bio Science Laboratory (JBSL) is approved in all 28 EU member states after being written into Official Journal of the European Union on 20 January. JBSL received a positive opinion from the European Food Safety Authority (EFSA) last year.
The approval is for “non-genetically modified soy beans (Glycine max (L.)) with a selected strain of Bacillus subtilis var. natto.”.
The approved extract contain natto which is a source of vitamin K2 but in this case isolates to nattokinase which has been linked to anti-blood clotting and other circulation and heart health benefits.
Some EU member states had expressed concern about the nutrient’s blood clotting effects, but EFSA concluded JBSL’s NSK-SD branded ingredient was safe under the conditions proposed.
These were specified as “food supplements in capsule, tablet or powder form intended for the adult population, excluding pregnant and lactating women with a maximum dose of 100 mg fermented soybean extract per day.”
Medical supervision was advised if consumed with medicines.
Natto is popular in Japan, the US and is approved for sue in the food supply in more than 10 countries.
Last year the company published research which showed blood benefits.
NutraIngredients Awards 2017 - Ingredient of the Year – Healthy AgeingHeart Health
Cardiovascular issues cost governments billions every year. Many are looking to nutrition to protect hearts and reduce unsustainable medical care costs.Our judges want to know how your nutrient helps a healthy heart beat.